These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 16403441

  • 21. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK.
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L.
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [Abstract] [Full Text] [Related]

  • 25. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.
    Aktaş Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P.
    Bioconjug Chem; 2005 Nov; 16(6):1503-11. PubMed ID: 16287248
    [Abstract] [Full Text] [Related]

  • 26. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ.
    Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
    [Abstract] [Full Text] [Related]

  • 27. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L, Tosi G, Ruozi B, Bondioli L, Vandelli MA, Forni F.
    Prog Brain Res; 2009 Nov; 180():35-69. PubMed ID: 20302828
    [Abstract] [Full Text] [Related]

  • 28. Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model.
    Cohen ZR, Zaubermann J, Harnof S, Mardor Y, Nass D, Zadicario E, Hananel A, Castel D, Faibel M, Ram Z.
    Neurosurgery; 2007 Apr; 60(4):593-600; discussion 600. PubMed ID: 17415195
    [Abstract] [Full Text] [Related]

  • 29. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM.
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [Abstract] [Full Text] [Related]

  • 30. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J, Jallouli Y, Barras A, Dupont N, Betbeder D.
    Prog Brain Res; 2009 Jul; 180():2-17. PubMed ID: 20302826
    [Abstract] [Full Text] [Related]

  • 31. Blood-brain barrier imaging and therapeutic potentials.
    Rebeles F, Fink J, Anzai Y, Maravilla KR.
    Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
    [Abstract] [Full Text] [Related]

  • 32. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Pardridge WM.
    Biotechnol Bioeng; 2007 Aug 15; 97(6):1376-86. PubMed ID: 17286273
    [Abstract] [Full Text] [Related]

  • 33. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 15; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 34. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
    Chai WY, Chu PC, Tsai MY, Lin YC, Wang JJ, Wei KC, Wai YY, Liu HL.
    J Control Release; 2014 Oct 28; 192():1-9. PubMed ID: 24969355
    [Abstract] [Full Text] [Related]

  • 35. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA, Gomes B, Coelho MA, do Carmo Pereira M, Rocha S.
    Nanomedicine (Lond); 2014 Apr 28; 9(5):709-22. PubMed ID: 24827845
    [Abstract] [Full Text] [Related]

  • 36. Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging.
    Pham W, Zhao BQ, Lo EH, Medarova Z, Rosen B, Moore A.
    Neuroimage; 2005 Oct 15; 28(1):287-92. PubMed ID: 16040255
    [Abstract] [Full Text] [Related]

  • 37. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
    Yan H, Wang L, Wang J, Weng X, Lei H, Wang X, Jiang L, Zhu J, Lu W, Wei X, Li C.
    ACS Nano; 2012 Jan 24; 6(1):410-20. PubMed ID: 22148835
    [Abstract] [Full Text] [Related]

  • 38. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
    Andrieux K, Couvreur P.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Jan 24; 1(5):463-74. PubMed ID: 20049811
    [Abstract] [Full Text] [Related]

  • 39. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
    Ulbrich K, Hekmatara T, Herbert E, Kreuter J.
    Eur J Pharm Biopharm; 2009 Feb 24; 71(2):251-6. PubMed ID: 18805484
    [Abstract] [Full Text] [Related]

  • 40. The blood-brain barrier as a target for pharmacological modulation.
    Bartus RT.
    Curr Opin Drug Discov Devel; 1999 Mar 24; 2(2):152-67. PubMed ID: 19649942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.